Skinvisible Revenue

Skinvisible had revenue of $5.00K in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $20.00K, down -91.08% year-over-year. In the year 2023, Skinvisible had annual revenue of $20.00K, down -92.84%.

Revenue (ttm)

$20.00K

Revenue Growth

-91.08%

P/S Ratio

152.08

Revenue / Employee

$10,000

Employees

Market Cap

3.04M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	20.00K	-259.30K	-92.84%
Dec 31, 2022	279.30K	-384.13K	-57.90%
Dec 31, 2021	663.43K	387.87K	140.76%
Dec 31, 2020	275.56K	232.39K	538.36%
Dec 31, 2019	43.17K	-26.18K	-37.75%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Walmart	657.33B
Costco	253.70B
PepsiCo	92.05B
Procter & Gamble	84.06B
Unilever	66.23B
Anheuser-Busch InBev	59.38B
The Coca-Cola Company	46.07B
Philip Morris International	36.45B

Revenue Rankings

SKVI News

15 days ago - Promising Data on Transdermal Obesity Formulations Announced by Skinvisible - Accesswire
4 weeks ago - Skinvisible Expands Obesity Patent Application for Transdermal Delivery - Accesswire
5 months ago - Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome - Accesswire
2 years ago - Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug - Accesswire

More News